首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   255篇
  免费   13篇
  国内免费   1篇
儿科学   12篇
妇产科学   21篇
基础医学   36篇
口腔科学   5篇
临床医学   26篇
内科学   28篇
皮肤病学   5篇
神经病学   12篇
特种医学   10篇
外科学   58篇
综合类   8篇
预防医学   27篇
药学   11篇
肿瘤学   10篇
  2021年   2篇
  2019年   3篇
  2018年   2篇
  2017年   2篇
  2016年   6篇
  2015年   3篇
  2014年   9篇
  2013年   7篇
  2012年   17篇
  2011年   9篇
  2010年   11篇
  2009年   5篇
  2008年   12篇
  2007年   12篇
  2006年   12篇
  2005年   9篇
  2004年   6篇
  2003年   8篇
  2002年   9篇
  2001年   3篇
  2000年   7篇
  1999年   7篇
  1998年   8篇
  1997年   2篇
  1996年   3篇
  1995年   4篇
  1994年   2篇
  1993年   2篇
  1992年   6篇
  1989年   3篇
  1988年   3篇
  1986年   9篇
  1985年   4篇
  1984年   3篇
  1979年   3篇
  1978年   1篇
  1977年   3篇
  1976年   6篇
  1975年   4篇
  1973年   3篇
  1972年   4篇
  1971年   5篇
  1970年   3篇
  1969年   2篇
  1968年   4篇
  1967年   2篇
  1966年   10篇
  1965年   3篇
  1963年   1篇
  1954年   1篇
排序方式: 共有269条查询结果,搜索用时 0 毫秒
81.
随着对海量数据处理的广泛需求,对数据库系统的性能也提出了更高的要求.本文介绍了一种带快照的混合数据库系统的设计.它在传统数据库系统基于磁盘存储的基础上,选择部分需被频繁或快速访问的数据以快照的形式组织在主存中,从而兼顾了处理海量数据和快速响应用户访问要求两方面的需求.最后,简要给出了一个在地理信息系统中的应用实例.  相似文献   
82.
83.
We have studied 24-h ambulatory blood pressure and kidney function in three groups of adult women: (1) born full term but with birth weights below the 3rd percentile for gestational age (n =18), (2) born preterm before gestational week 33 (median birth weight 1,250 g, range 950–2,040 g) (ex-preterm, n =14), and (3) those born full term with normal birth weights (comparison group n =17). We have previously published the results from the study. We recalculated the daily ambulatory blood pressure and redefined the time interval from 6:00–24:00 to 8:00–20:00, since this better corresponds to daily active life. We found significantly increased mean daily systolic ambulatory blood pressure in the ex-preterm group. The result supports the suggestion that disturbance and/or disruption of the normal prenatal milieu seem to affect arterial blood pressure in adult life.  相似文献   
84.
85.
PURPOSE: Current techniques to treat venous ulcerations and patients with severe lipodermatosclerosis include the elimination of incompetent perforator veins by open surgical ligation and division or by subfascial endoscopic perforator surgery. An alternative and less invasive means to obliterate perforator veins is ultrasound-guided sclerotherapy (UGS). We hypothesize that UGS is a clinically effective means of eliminating perforator veins and results in improvement of the clinical state (scores) without the complications associated with other more invasive methods. METHODS: Between January 2000 and March 2004, UGS was used to treat chronic venous insufficiency in 80 limbs of 68 patients. This was a clinical series of patients who had perforator incompetence and no previous surgery for venous disease < or = 2 years of their UGS procedure. Most had perforator disease without coexisting axial reflux of the saphenous or deep venous systems. Color flow duplex scanning was used to identify incompetent perforator veins in the calf, and duplex guidance was used to inject each perforator with the liquid sclerosant sodium morrhuate (5%). Patients were restudied by duplex scanning up to 5 years after treatment. Clinical results were determined by Venous Clinical Severity Score (VCSS) and Venous Disability Score (VDS) before and after treatment. RESULTS: Of the 80 limbs treated with UGS, 98% of incompetent perforators were successfully obliterated at the time of treatment, and 75% of limbs showed persistent occlusion of perforators and remained clinically improved with a mean follow-up of 20.1 months. According to the CEAP classification, there were 46.2% with limb ulceration or C6, 1.2% C5, 28.7% C4, 17.5% C3, and 6.2% C2 with pain isolated to the site of the perforator(s). Of those who returned for follow-up, the VCSSs changed from a median of 8 before treatment (95% confidence interval [CI], 3 to 15) to a median of 2 after treatment (95% CI, 0 to 7) (P < .01). Likewise, VDSs dropped from a median of 4 before treatment (95% CI, 1 to 3) to 1 after treatment (95% CI, 0 to 2) (P < .01). There were no cases of deep vein thrombosis involving the deep vein adjacent to the perforator injected. One patient had skin complications with skin necrosis. Perforator recurrence was found more frequently in those with ulcerations than those without. CONCLUSION: UGS is an effective and durable method of eliminating incompetent perforator veins and results in significant reduction of symptoms and signs as determined by venous clinical scores. As an alternative to open interruption or subfascial endoscopic perforator surgery, UGS may lead to fewer skin and wound healing complications. Perforator recurrence occurs particularly in those with ulcerations, and therefore, surveillance duplex scanning after UGS and repeat injections may be needed.  相似文献   
86.
OBJECTIVE: We compared the hemodynamic effects of different mechanical devices aimed for prevention of travel-related deep venous thrombosis with active foot movements. METHODS: Two battery-operated intermittent pneumatic compression (IPC) devices and three foot and calf muscle pump facilitating devices (PFD) that claimed to prevent travel-related deep venous thrombosis were tested in 17 healthy volunteers on the ground and in 8 of same volunteers during flight. Flow changes during active foot movements were compared with the effects of each of the tested devices. RESULTS: There was no significant difference in hemodynamic effect between PFDs and active foot movements. The hemodynamic effects of IPC devices were significantly less compared with active foot movements. Values obtained during air flights were not significantly different from those obtained on the ground. CONCLUSIONS: Whereas IPC use for prevention of venous stasis during flight can be justified for immobile patients or during sleep, PFDs do not provide additional hemodynamic benefits compared with simple movements of the foot.  相似文献   
87.
背景与目的:食用真菌在医疗保健领域的研究展现出强大的应用潜力.该课题探讨全复配食用菌提取物的抗肿瘤作用及对荷瘤小鼠免疫功能的影响.方法:小鼠随机编号分组,其中预防组预先给予全复配食用菌提取物灌胃2周,每天1次,之后各组均接种C26细胞建立荷瘤小鼠模型,接种后第2天给小鼠予以不同制剂灌胃(空白组灌0.9%氯化钠溶液,治疗组、预防阻灌复配食用菌提取物,CTX阳性组腹腔注射CTX)每天1次,观察记录小鼠一般状态,2周后处死小鼠无菌取脾脏、取瘤称重.MTT法检测小鼠脾淋巴细胞转化功能,乳酸脱氢酶(LDH)法检测NK细胞杀伤活性.结果:复配食用菌提取物预防组对小鼠C26肿瘤有30.4%的抑制率;小鼠脾淋巴细胞在ConA刺激下的增殖能力和NK细胞杀伤功能均显著高于空白组.结论:复配食用菌提取物预防性摄入对再接种C26小鼠有抑瘤和免疫增强作用.  相似文献   
88.
A prospective study comparing duplex scanning and descending venography was applied to 143 venous segments in 25 extremities with moderate to severe manifestations of chronic venous insufficiency (class 2 or 3). Duplex scanning was performed with the patient in the 15 degree reverse Trendelenburg position, and descending venography with the patient in the 60 degrees semi-erect position; the Valsalva maneuver was used to elicit reflux in both tests. The duplex parameter of reflux duration greater than 0.5 second correlated with venographic reflux in 94 of 105 segments (sensitivity of 90%). Conversely, reflux time less than or equal to 0.5 second correlated with venographic competence in 32 of 38 segments (specificity of 84%). A total of 17 discrepancies were identified among the 143 total segments studied, for an accuracy of 88%. The largest proportion of discrepancies was identified in the group with venographic competence and reflux duration greater than 0.5 second and less than or equal to 2.0 seconds; this was designated a gray zone. Mean peak velocities were significantly higher in the reflux group when compared with the competence group in the profunda femoris vein (p = 0.047), greater saphenous vein (p less than 0.001), popliteal vein (p less than 0.001), and tibial vein (p = 0.005). We conclude that venographic reflux correlates best with duplex scan findings of reflux duration greater than 0.5 second. Duration of reflux greater than 0.5 second and less than or equal to 2.0 seconds, however, represents a gray zone and should be interpreted with caution since this could lead to over-reading of reflux disease, in which case verification of incompetence by descending venography may be indicated.  相似文献   
89.
90.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号